Locations
San Diego, CA, USA · La Jolla, San Diego, CA, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Series C+
founded in
2014
Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind expanded genetic alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at the Scripps Research Institute. Synthorx is headquartered in La Jolla, California.
Something looks off?On-site & Remote